Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Medica Sur SAB de CV stock price, quote, forecast and news

MEDICAB.MX
MXP510121215
A1JHBB

Price

34.69 MXN
Today +/-
+0.02 MXN
Today %
+1.42 %
P

Medica Sur SAB de CV stock price

MXN
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Medica Sur SAB de CV stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medica Sur SAB de CV stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medica Sur SAB de CV stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medica Sur SAB de CV's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medica Sur SAB de CV Stock Price History

DateMedica Sur SAB de CV Price
8/23/202434.69 MXN
8/22/202434.20 MXN
8/19/202434.71 MXN
8/14/202435.00 MXN
8/13/202434.49 MXN
8/12/202434.50 MXN
8/9/202434.50 MXN
8/8/202434.50 MXN
8/7/202434.50 MXN
8/6/202435.00 MXN
8/5/202435.74 MXN
8/2/202435.74 MXN
8/1/202435.79 MXN
7/31/202435.87 MXN
7/30/202435.80 MXN
7/29/202435.97 MXN

Medica Sur SAB de CV Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Medica Sur SAB de CV, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medica Sur SAB de CV from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medica Sur SAB de CV’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medica Sur SAB de CV. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medica Sur SAB de CV’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medica Sur SAB de CV’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medica Sur SAB de CV’s growth potential.

Medica Sur SAB de CV Revenue, EBIT and net profit per share

DateMedica Sur SAB de CV RevenueMedica Sur SAB de CV EBITMedica Sur SAB de CV Net Income
2024e5.96 B MXN0 MXN123.28 M MXN
20234.13 B MXN623.89 M MXN634.98 M MXN
20223.87 B MXN574.76 M MXN949.8 M MXN
20213.81 B MXN734.56 M MXN1.15 B MXN
20203.19 B MXN626.96 M MXN558.83 M MXN
20193.7 B MXN365.3 M MXN140.55 M MXN
20183.61 B MXN399.01 M MXN156.15 M MXN
20173.43 B MXN510.91 M MXN231.8 M MXN
20162.51 B MXN211.7 M MXN142.63 M MXN
20152.28 B MXN331.24 M MXN241.02 M MXN
20142.29 B MXN464.7 M MXN349.08 M MXN
20132.26 B MXN496.7 M MXN379.8 M MXN
20122.09 B MXN401.7 M MXN300.5 M MXN
20111.92 B MXN323.2 M MXN224 M MXN
20101.82 B MXN355 M MXN231.3 M MXN
20091.78 B MXN372.6 M MXN236.8 M MXN
20081.56 B MXN302.3 M MXN193.7 M MXN
20071.4 B MXN288.1 M MXN216.3 M MXN
20061.24 B MXN268.1 M MXN194.2 M MXN
20051.07 B MXN234.4 M MXN144.5 M MXN
2004952.2 M MXN204.9 M MXN131.8 M MXN

Medica Sur SAB de CV Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B MXN)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B MXN)EBIT (M MXN)EBIT MARGIN (%)NET INCOME (B MXN)NET INCOME GROWTH (%)DIV. (MXN)DIV. GROWTH (%)SHARES (M)DOCUMENTS
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e
0.180.20.290.430.590.690.790.870.951.071.241.41.561.781.821.922.092.262.292.282.513.433.613.73.193.813.874.135.96
-14.1241.0951.9337.1816.1614.209.7710.0612.2915.6213.0311.3814.652.135.608.637.941.60-0.6110.1836.695.132.52-13.6619.391.446.7844.44
35.5947.0341.0544.1148.6548.2648.1040.4636.7636.2036.8137.1534.8335.8735.1331.9134.0736.7034.4731.1230.9233.8730.8029.5337.7739.4335.3535.34-
0.060.10.120.190.290.330.380.350.350.390.460.520.540.640.640.610.710.830.790.710.781.161.111.091.211.51.371.460
761228881511732092032042342682883023723553234014964643312115103993656267345746230
42.945.949.8220.3225.4225.0726.5223.4721.4321.8921.6820.6219.4120.8519.4816.7919.1921.9920.2414.538.4114.8611.069.8719.6119.2514.8415.09-
0.05000.030.040.070.10.110.130.140.190.220.190.240.230.220.30.380.350.240.140.230.160.140.561.150.950.630.12
--95.56-50.003,200.009.09102.7842.477.6916.969.9234.7211.34-10.6522.28-2.12-3.0333.9326.33-7.92-30.95-41.0862.68-32.47-10.26298.57106.81-17.76-33.19-80.60
-----------------------------
-----------------------------
107.5107.5107.5119.1115122.7117.8117.8117.8117.8117.8117.8117.8117.8117.8123.3123.3123.3123.28123.28123.28123.28123.28123.28123.28123.28107.94107.940
-----------------------------
Details

Keystats

Revenue and Growth

The Medica Sur SAB de CV Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medica Sur SAB de CV is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B MXN)RECEIVABLES (M MXN)OTHER REC. (M MXN)INVENTORIES (M MXN)OTHER CURRENT LIAB. (M MXN)CURRENT ASSETS (B MXN)TANGIBLE ASSETS (B MXN)LONG-T. INVEST. (M MXN)LONG-T. REC. (M MXN)INTANGIBLE ASSETS (M MXN)GOODWILL (B MXN)OTHER NON-CURRENT ASSETS (M MXN)NON-CURRENT ASSETS (B MXN)TOTAL ASSETS (B MXN)LIABILITIESCOMMON STOCK (M MXN)ADDITIONAL PAID-IN CAPITAL (M MXN)RETAINED EARNINGS (B MXN)OTHER EQUITY (M MXN)UNREAL. GAINS/LOSSES (M MXN)EQUITY (B MXN)LIABILITIES (M MXN)PROVISIONS (M MXN)OTHER SHORT-TERM LIAB. (M MXN)SHORT-TERM DEBTS (M MXN)LONG-TERM DEBT PORTION (M MXN)SHORT-TERM REC. (B MXN)LONG-T. LIAB. (B MXN)DEFERRED TAXES (M MXN)OTHER LIAB. (B MXN)LONG-T. LIABILITIES (B MXN)DEBT (B MXN)TOTAL CAPITAL (B MXN)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00.0300.010.060.060.090.030.020.020.030.010.250.110.10.370.250.180.340.360.10.120.170.280.573.531.220.7
4.78.517.73552.359.265.360.664.880.184.2100.7109110118.3121.3168.8177.9157.87162.15243.02313.44336.68373.37592.47439.39295.53334.59
180.911.94.562.625.213.317.852.935.461.340.17360.56238.850.538.73.16.184.2460.44196.6293.339.1728.2317.2413.8470.47
50.750.867.379.5127132.1147.423.633.123.323.234.440.544.145.243.545.567.455.965117.71133.83102.45102.52155.38129.51139.22140.84
3.811.110026.1000000016.1014.2193.063.92476.95342.77346.66250.92269.3215.1615.0721.48
0.240.120.090.190.270.270.330.160.150.180.180.220.460.330.320.590.520.440.570.5911.11.051.041.624.131.691.27
0.280.40.510.530.580.60.630.851.041.181.321.531.662.172.162.152.172.462.732.842.762.852.793.213.072.582.492.41
00013.400001.64.33.44.55.4810.411.4435.2195.1126.04105.2797.3489.8382.968080.2473.42201.38190.18
014.934.30000010.90.20.3000000000000004.340
000000000000000010.29.308.4479.47444.67407.41365.9351.61000
0000.010.120.110.100000.20.290.290.290.270.220.220.220.221.121.121.121.031.030.120.120.12
00.20.40.10.19.19.7183.7192.2189.5195.935.316.916.614.913.8000000108.84122.36138.0875.6777.88134.9
0.280.410.540.560.710.720.751.041.231.381.521.771.972.482.482.442.842.893.083.184.464.54.514.84.662.852.92.86
0.520.530.630.750.970.991.071.21.391.561.71.992.432.812.83.033.363.343.643.775.465.65.565.856.286.984.584.13
275.5376.2340.2593377.3605.5640665.4699.9353.3353.3780.7780.7780.7780.7798.4517.9517.9517.87517.87517.87517.87517.87517.87517.87517.87453.42453.42
50.279.5200.80.22.81.71.81.92372401.322200121.3121.3121.28121.28121.28121.28121.28121.28121.28121.28121.28121.28
00.020.020.090.120.140.230.320.430.540.710.890.760.931.11.251.952.122.472.62.662.812.93.053.384.281.961.47
000-59.7-166.5-196.9-210.1-218.8-230.1-237.8-247.4-256.7002121.90-0.9-0.23-0.531.41-0.69-0.09-4.01-9.98-8.72-9.74-12.47
0000000000000000000000000000
0.330.470.570.630.330.550.660.770.91.031.211.411.541.721.882.172.592.763.113.243.33.453.543.684.014.912.522.04
4.45.814.447.471.442.664.458.967.676.188.1110.990.9106.995.9129.1151163.9157.81128.01343.78261.69217.22241.7345.92269.14280.77275.75
0000000000000000216.47.2214.3135.3256.8211.927.3215.09121.61149.15132.64
23.715.717.418.91127.531.747.191.675.55469.4105.4244.2177517.4206219219.79248.26304.86352.8540.09296.39495.67590.91555.59610.4
0000000000000000000000000000
1.58.820.343.963.345.617.62842.656.692.587.413938.97.13.2170.1000303038.27418.23107.0322.1811.8120.73
0.030.030.050.110.150.120.110.130.20.210.230.270.340.390.280.650.550.390.380.390.710.70.810.960.96111.04
0.080.0100.010.210.150.110.080.10.0900.030.260.120.39000001.281.3501.111.21.031.021.01
0000141.4174187.4216.4190.9221.7231.7264.4267.5256.8220.6167.8211.8178.6146.53125.1290.3370.2599.6958.773.48000
0.010.010.010000000.010.010.020.020.330.030.030.010.010.010.010.060.031.110.030.040.030.030.04
0.090.020.020.010.350.330.30.290.290.320.250.310.550.710.640.210.220.190.160.141.441.451.211.21.311.071.061.05
0.120.050.070.120.50.440.410.430.490.530.480.580.891.10.920.860.770.580.540.532.152.162.012.162.272.072.052.09
0.450.530.630.750.830.991.071.21.391.561.71.992.432.812.83.033.363.343.653.775.455.65.565.856.286.984.584.13
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Medica Sur SAB de CV provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medica Sur SAB de CV's financial health and stability.

Assets

Medica Sur SAB de CV's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medica Sur SAB de CV must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medica Sur SAB de CV after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medica Sur SAB de CV's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B MXN)DEPRECIATION (M MXN)DEFERRED TAXES (M MXN)CHANGES IN WORKING CAPITAL (M MXN)NON-CASH ITEM (M MXN)PAID INTEREST (M MXN)PAID TAXES (M MXN)NET CASH FLOW FROM OPERATING ACTIVITIES (B MXN)CAPITAL EXPENDITURES (M MXN)CASH FLOW FROM INVESTING ACTIVITIES (B MXN)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B MXN)INTEREST INCOME AND EXPENSES (M MXN)NET DEBT CHANGE (B MXN)NET CHANGE IN EQUITY (M MXN)CASH FLOW FROM FINANCING ACTIVITIES (B MXN)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M MXN)TOTAL DIVIDENDS PAID (M MXN)NET CHANGE IN CASH FLOW (B MXN)FREE CASH FLOW (M MXN)SHARE-BASED COMPENSATION (M MXN)
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.04000.030.040.070.10.110.130.140.190.220.260.350.340.310.420.50.470.350.150.230.170.140.561.150.950.63
17192730466265516586102103126127120140108109117121325220225350323277166178
000012263000000000000000000000
-14160-7-9173-13-710724-308-35-123-63-147-148-182-100-105-147-353-480-335-139-192-306-701-422
1157-1428262830132027154460-19-9380242247233411-303-145-38
0000000000001122621430020133144000070
00000000000050120129174136116144133143170156144127255379356
-0.080.080.030.060.260.150.170.30.250.230.320.310.290.430.320.350.340.490.470.330.20.210.310.581.10.820.270.35
-6-76-67-25-30-44-53-324-238-193-194-275-102-244-98-90-3-216-316-228-230-266-179-137-128-150-186-213
-0.01-0.08-0.07-0.05-0.3-0.05-0.05-0.32-0.24-0.2-0.19-0.27-0.27-0.24-0.09-0.07-0.22-0.21-0.3-0.21-1.66-0.08-0.02-0.33-0.112.560.730.23
000-0.03-0.27-000-0-000-0.170.010.010.02-0.210.010.020.02-1.430.180.16-0.190.022.710.920.45
0000000000000000000000000000
-0.01-0.08-0.010.010.21-0.12-0.08-00.030.01-0.060.010.29-0.24-0.17-0.08-0.16-0.17-0.1701.290.07-0.250.02-0.32-0.11-0.02-0.02
981247-7-80000000000170000000-2-230-80-206-429
0.090.0300.010.09-0.11-0.1-0.04-0.02-0.04-0.11-0.050.22-0.32-0.24-0-0.25-0.36-0.01-0.11.2-0.02-0.33-0.15-0.69-0.42-3.31-1.1
0000-109253-8-5-200-11-22-6117-23000000-159-138-70-700
-1-1300-11-15-19-26-43-46-52-62-61-60-64-64-67-189-9-100-80-82-72-10-161-3,019-659
00.03-0.040.010.05-00.02-0.07-0.01-0.010.01-0.020.24-0.13-0.010.27-0.12-0.070.170.01-0.250.11-0.050.110.32.96-2.31-0.52
-86.86.2-40.236.3226.1105.3120.7-28.511.837.212429.6189.4183.3218.1259.2340.7277.5157.8999.45-31.54-52.17125.99447.24972.8670.5383.64139.56
0000000000000000000000000000

Medica Sur SAB de CV stock margins

The Medica Sur SAB de CV margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medica Sur SAB de CV. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medica Sur SAB de CV.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medica Sur SAB de CV's sales revenue. A higher gross margin percentage indicates that the Medica Sur SAB de CV retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medica Sur SAB de CV's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medica Sur SAB de CV's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medica Sur SAB de CV's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medica Sur SAB de CV. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medica Sur SAB de CV's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medica Sur SAB de CV Margin History

Medica Sur SAB de CV Gross marginMedica Sur SAB de CV Profit marginMedica Sur SAB de CV EBIT marginMedica Sur SAB de CV Profit margin
2024e35.34 %0 %2.07 %
202335.34 %15.11 %15.38 %
202235.35 %14.86 %24.56 %
202139.45 %19.27 %30.28 %
202037.77 %19.63 %17.5 %
201929.54 %9.88 %3.8 %
201830.8 %11.06 %4.33 %
201733.89 %14.89 %6.76 %
201630.94 %8.43 %5.68 %
201531.13 %14.54 %10.58 %
201434.5 %20.27 %15.23 %
201336.7 %22.01 %16.83 %
201234.07 %19.22 %14.38 %
201131.92 %16.79 %11.64 %
201035.16 %19.48 %12.69 %
200935.87 %20.88 %13.27 %
200834.88 %19.43 %12.45 %
200737.17 %20.62 %15.48 %
200636.83 %21.68 %15.7 %
200536.24 %21.92 %13.51 %
200436.84 %21.52 %13.84 %

Medica Sur SAB de CV Stock Sales Revenue, EBIT, Earnings per Share

The Medica Sur SAB de CV earnings per share therefore indicates how much revenue Medica Sur SAB de CV has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Medica Sur SAB de CV earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medica Sur SAB de CV's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medica Sur SAB de CV’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medica Sur SAB de CV's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medica Sur SAB de CV Revenue, EBIT and net profit per share

DateMedica Sur SAB de CV Sales per ShareMedica Sur SAB de CV EBIT per shareMedica Sur SAB de CV Earnings per Share
2024e48.38 MXN0 MXN1 MXN
202338.26 MXN5.78 MXN5.88 MXN
202235.83 MXN5.32 MXN8.8 MXN
202130.92 MXN5.96 MXN9.36 MXN
202025.9 MXN5.09 MXN4.53 MXN
201930 MXN2.96 MXN1.14 MXN
201829.26 MXN3.24 MXN1.27 MXN
201727.83 MXN4.14 MXN1.88 MXN
201620.36 MXN1.72 MXN1.16 MXN
201518.48 MXN2.69 MXN1.96 MXN
201418.59 MXN3.77 MXN2.83 MXN
201318.3 MXN4.03 MXN3.08 MXN
201216.95 MXN3.26 MXN2.44 MXN
201115.61 MXN2.62 MXN1.82 MXN
201015.47 MXN3.01 MXN1.96 MXN
200915.15 MXN3.16 MXN2.01 MXN
200813.21 MXN2.57 MXN1.64 MXN
200711.86 MXN2.45 MXN1.84 MXN
200610.5 MXN2.28 MXN1.65 MXN
20059.08 MXN1.99 MXN1.23 MXN
20048.08 MXN1.74 MXN1.12 MXN

Medica Sur SAB de CV business model

Medica Sur SAB de CV is a leading Mexican healthcare company that was originally founded in 1982. Headquartered in Mexico City, Medica Sur operates hospitals, medical clinics, laboratories, and diagnostic centers throughout the country. The company aims to provide comprehensive and high-quality healthcare and has earned an outstanding reputation through its innovative medical technology and expertise. The core business of Medica Sur includes the operation of seven hospitals and clinical facilities in various parts of the country. These facilities provide medical services in general medicine, internal medicine, neurology, oncology, gynecology, urology, pediatrics, ophthalmology, and clinical psychiatry. The company also operates its own laboratory and diagnostic center, where a wide range of tests are performed, including X-rays and CT scans, blood tests, and biopsy examinations. Medica Sur also has a subsidiary called Hospitales Angeles, which specializes in cosmetic surgery. These facilities offer a wide range of beauty treatments, including liposuction, breast augmentation, facelifts, and Botox injections. Another important business area for Medica Sur is education and research. The company operates a prestigious training program for medical professionals such as nurses, specialists, and general practitioners. Furthermore, Medica Sur is active in medical research and invests in innovative technologies and scientific developments aimed at improving the quality and effectiveness of medical care. One of Medica Sur's biggest innovations is the use of robotics in surgery. The company utilizes robots that can respond to the surgeon's movements, thereby enabling higher precision in performing operations. The use of this technology has contributed to the advancement of surgery and opened up new treatment options for patients. Overall, Medica Sur's business model is designed to provide comprehensive and high-quality healthcare in Mexico tailored to the needs and expectations of patients. The company aims to be a leading healthcare company that utilizes innovative technologies and top-notch expertise to improve people's lives. Medica Sur SAB de CV is one of the most popular companies on Eulerpool.com.

Medica Sur SAB de CV SWOT Analysis

Strengths

Medica Sur SAB de CV possesses several strengths:

  • Strong brand reputation and recognition in the healthcare industry.
  • Extensive network of hospitals and medical centers.
  • Advanced medical technology and state-of-the-art facilities.
  • Skilled and experienced healthcare professionals.
  • Solid financial performance and stable revenue streams.

Weaknesses

Despite its strengths, Medica Sur SAB de CV faces certain weaknesses:

  • Relatively high prices for its services.
  • Limited presence in certain geographical areas.
  • Dependency on third-party payers for revenue.
  • Challenges in managing patient influx during peak periods.

Opportunities

Medica Sur SAB de CV can capitalize on the following opportunities:

  • Growing demand for quality healthcare services.
  • Expansion into untapped markets or underserved regions.
  • Increased healthcare spending by governments and individuals.
  • Strategic partnerships or collaborations with other healthcare providers.
  • Development and implementation of telemedicine solutions.

Threats

However, Medica Sur SAB de CV should be cautious of the following threats:

  • Intense competition from other healthcare providers.
  • Potential regulatory changes affecting healthcare policies.
  • Economic downturns that may impact patients' ability to afford healthcare.
  • Technological advancements that may render current medical equipment obsolete.
  • Emerging infectious diseases and pandemics.

Medica Sur SAB de CV Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medica Sur SAB de CV historical P/E ratio, EBIT, and P/S ratio.

Medica Sur SAB de CV shares outstanding

The number of shares was Medica Sur SAB de CV in 2023 — This indicates how many shares 107.939 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Medica Sur SAB de CV earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medica Sur SAB de CV's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medica Sur SAB de CV’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medica Sur SAB de CV's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medica Sur SAB de CV Stock splits

In Medica Sur SAB de CV's history, there have been no stock splits.

Medica Sur SAB de CV dividend history and estimates

In 2023, Medica Sur SAB de CV paid a dividend amounting to 13.06 MXN. Dividend means that Medica Sur SAB de CV distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Medica Sur SAB de CV provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Medica Sur SAB de CV’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Medica Sur SAB de CV's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Medica Sur SAB de CV Dividend History

DateMedica Sur SAB de CV Dividend
2024e14.66 MXN
202313.06 MXN
202210.49 MXN
20211.5 MXN
20180.61 MXN
20170.7 MXN
20160.68 MXN
20150.85 MXN
20131.7 MXN
20120.55 MXN
20110.58 MXN
20100.58 MXN
20090.54 MXN
20080.54 MXN
20070.51 MXN
20060.43 MXN
20050.38 MXN
20040.36 MXN

Medica Sur SAB de CV dividend payout ratio

In 2023, Medica Sur SAB de CV had a payout ratio of 66.93%. The payout ratio indicates the percentage of the company's profits that Medica Sur SAB de CV distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Medica Sur SAB de CV represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Medica Sur SAB de CV could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Medica Sur SAB de CV's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Medica Sur SAB de CV Payout Ratio History

DateMedica Sur SAB de CV Payout ratio
2024e67.41 %
202366.93 %
2022119.29 %
202116.03 %
202065.48 %
201961.12 %
201848.03 %
201737.23 %
201659.13 %
201543.48 %
201461.12 %
201355.32 %
201222.54 %
201131.7 %
201029.43 %
200926.62 %
200833.11 %
200727.67 %
200626.27 %
200531.29 %
200431.82 %
Unfortunately, there are currently no price targets and forecasts available for Medica Sur SAB de CV.

Eulerpool ESG Scorecard© for the Medica Sur SAB de CV stock

Eulerpool World ESG Rating (EESG©)

66/ 100

🌱 Environment

56

👫 Social

86

🏛️ Governance

56

Environment

Scope 1 - Direct Emissions
1,412.65
Scope 2 - Indirect emissions from purchased energy
5,483.9
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
6,896.55
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees60
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Medica Sur SAB de CV list of shareholders

%
Name
Stocks
Change
Date
57.22 % Neuco, S.A. de C.V.70,541,8178,777,06712/31/2022
1.70 % GBM Administradora de Activos, SA de CV, Sociedad Operadora de Fondos de2,099,89304/30/2023
1.25 % Fidelity Management & Research Company LLC1,546,804-2,8391/31/2024
0.80 % Fidelity Institutional Asset Management989,18926,2618/31/2023
0.39 % Operadora Inbursa de Sociedades de Inversión, S.A. de C.V.480,35604/30/2023
0.39 % Finaccess México, S.A. de C.V.475,90002/29/2024
0.05 % Fidelity Investments Canada ULC56,70720712/31/2023
0.04 % Actinver S.A. de C.V.43,68502/29/2024
0.03 % Operadora de Fondos GBM S.A.B. de C.V.38,550-83,3421/31/2024
0.02 % Dimensional Fund Advisors, L.P.22,37002/29/2024
1
2

Most common questions regarding Medica Sur SAB de CV

What values and corporate philosophy does Medica Sur SAB de CV represent?

Medica Sur SAB de CV represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality healthcare services to its patients, focusing on excellence, compassion, and innovation. Medica Sur is dedicated to providing personalized care that puts the patient's needs at the forefront. With a patient-centric approach, Medica Sur values integrity, professionalism, and ethical practices. The company strives to continuously improve its services and invest in cutting-edge technologies to ensure the best healthcare outcomes for its patients. Medica Sur SAB de CV is dedicated to making a positive impact on the healthcare industry while upholding its core values.

In which countries and regions is Medica Sur SAB de CV primarily present?

Medica Sur SAB de CV is primarily present in Mexico.

What significant milestones has the company Medica Sur SAB de CV achieved?

Medica Sur SAB de CV has achieved several significant milestones throughout its history. Firstly, the company has successfully established itself as one of the leading healthcare providers in Mexico, offering a wide range of medical services and specialties. Additionally, Medica Sur has consistently received recognition for its outstanding quality of care and patient satisfaction. The company has also expanded its operations by opening new hospital facilities and investing in state-of-the-art technology. Furthermore, Medica Sur has demonstrated its commitment to research and education, collaborating with renowned academic institutions and contributing to advancements in the field of medicine. These achievements highlight Medica Sur's strong position in the healthcare industry.

What is the history and background of the company Medica Sur SAB de CV?

Medica Sur SAB de CV, a renowned healthcare provider, has a rich history and background. Established in 1968, the company has evolved into one of Mexico's leading medical institutions. Medica Sur operates multiple hospitals, clinics, and specialized centers, offering a comprehensive range of medical services. With a commitment to quality healthcare, Medica Sur has achieved various accreditations and certifications, ensuring patient-centric care. The company's success lies in its state-of-the-art facilities, cutting-edge technology, and a team of highly skilled medical professionals. Medica Sur focuses on delivering outstanding healthcare services, making it a trusted name in the industry and a preferred choice for patients in Mexico.

Who are the main competitors of Medica Sur SAB de CV in the market?

The main competitors of Medica Sur SAB de CV in the market include Grupo Angeles Health Services, Hospiten Group, and Star Médica.

In which industries is Medica Sur SAB de CV primarily active?

Medica Sur SAB de CV is primarily active in the healthcare industry.

What is the business model of Medica Sur SAB de CV?

Medica Sur SAB de CV operates as a healthcare services provider in Mexico. The company's business model revolves around offering a comprehensive range of medical services to patients. Medica Sur SAB de CV owns and manages hospitals, clinics, and specialized centers, with a primary focus on high-quality healthcare delivery. It strives to provide cutting-edge medical technology, experienced healthcare professionals, and patient-centered care. Medica Sur SAB de CV's business model emphasizes operational efficiency and excellence, aiming to meet the diverse healthcare needs of individuals and communities.

What is the P/E ratio of Medica Sur SAB de CV 2024?

The Medica Sur SAB de CV P/E ratio is 30.37.

What is the P/S ratio of Medica Sur SAB de CV 2024?

The Medica Sur SAB de CV P/S ratio is 0.63.

What is the AlleAktien quality score of Medica Sur SAB de CV?

The AlleAktien quality score for Medica Sur SAB de CV is 7/10.

What is the revenue of Medica Sur SAB de CV 2024?

The expected Medica Sur SAB de CV revenue is 5.96 B MXN.

How high is the profit of Medica Sur SAB de CV 2024?

The expected Medica Sur SAB de CV profit is 123.28 M MXN.

What is the business model of Medica Sur SAB de CV

The company Medica Sur SAB de CV is a leading company in the Mexican healthcare market that offers a wide range of medical services and products to its customers. The company's business model is based on the goal of providing patients with top-quality care while achieving high profitability for its investors. Medica Sur operates a chain of medical facilities, including important public and private hospitals, clinics, and medical centers. The company's medical divisions include specialties such as cardiology, surgery, gynecology, neurology, oncology, and internal medicine. The company places great importance on quality and relies on highly trained personnel, state-of-the-art medical equipment, and innovative technologies. Patients can depend on receiving top-notch treatment, no matter what kind of medical problem they have. The company's employees work closely together to ensure the highest possible standards of patient safety and care. Medica Sur also offers a range of products for hospital and clinic needs. These include medical devices, consumables, disposable items, and pharmaceutical products. The company sources these products exclusively from reputable suppliers to ensure they meet strict quality and safety standards. The company's business model offers investors an attractive opportunity to participate in the growth of the healthcare market in Mexico. Medica Sur has achieved a strong position in this market through successful expansion and acquisitions in recent years. The company also plans to continue its growth in the future by improving existing facilities, opening new locations, and expanding its range of medical products. Overall, Medica Sur positions itself as a company focused on quality, innovation, safety, and excellence in healthcare. The company has a strong reputation in the industry and is well positioned to benefit from the constantly increasing demand for medical services and products in Mexico.

What is the Medica Sur SAB de CV dividend?

Medica Sur SAB de CV pays a dividend of 10.49 MXN distributed over payouts per year.

How often does Medica Sur SAB de CV pay dividends?

The dividend cannot currently be calculated for Medica Sur SAB de CV or the company does not pay out a dividend.

What is the Medica Sur SAB de CV ISIN?

The ISIN of Medica Sur SAB de CV is MXP510121215.

What is the Medica Sur SAB de CV WKN?

The WKN of Medica Sur SAB de CV is A1JHBB.

What is the Medica Sur SAB de CV ticker?

The ticker of Medica Sur SAB de CV is MEDICAB.MX.

How much dividend does Medica Sur SAB de CV pay?

Over the past 12 months, Medica Sur SAB de CV paid a dividend of 13.06 MXN . This corresponds to a dividend yield of about 37.65 %. For the coming 12 months, Medica Sur SAB de CV is expected to pay a dividend of 13.06 MXN.

What is the dividend yield of Medica Sur SAB de CV?

The current dividend yield of Medica Sur SAB de CV is 37.65 %.

When does Medica Sur SAB de CV pay dividends?

Medica Sur SAB de CV pays a quarterly dividend. This is distributed in the months of June, October, June, June.

How secure is the dividend of Medica Sur SAB de CV?

Medica Sur SAB de CV paid dividends every year for the past 4 years.

What is the dividend of Medica Sur SAB de CV?

For the upcoming 12 months, dividends amounting to 13.06 MXN are expected. This corresponds to a dividend yield of 37.65 %.

In which sector is Medica Sur SAB de CV located?

Medica Sur SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medica Sur SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medica Sur SAB de CV from 5/16/2024 amounting to 1.5 MXN, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.

When did Medica Sur SAB de CV pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of Medica Sur SAB de CV in the year 2023?

In the year 2023, Medica Sur SAB de CV distributed 10.485 MXN as dividends.

In which currency does Medica Sur SAB de CV pay out the dividend?

The dividends of Medica Sur SAB de CV are distributed in MXN.

All fundamentals about Medica Sur SAB de CV

Our stock analysis for Medica Sur SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medica Sur SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.